Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Catalyst Pharmaceuticals Stock Price, Quotes and Forecasts
CPRXNASDAQ
Catalyst Pharmaceuticals (CPRX) Forecast
NewsEarningsCatalyst Pharmaceuticals (CPRX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Catalyst Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:CPRX | Benzinga
Explore Catalyst Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CPRX.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Catalyst Pharmaceuticals (CPRX) stock?
You can purchase shares of Catalyst Pharmaceuticals (NASDAQ:CPRX) through any online brokerage.
Who are Catalyst Pharmaceuticals (CPRX) competitors?
Other companies in Catalyst Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the forecast, or price target, for Catalyst Pharmaceuticals (CPRX) stock?
Catalyst Pharmaceuticals has a consensus price target of $29.55.
What is the current price for Catalyst Pharmaceuticals (CPRX)?
The stock price for Catalyst Pharmaceuticals (NASDAQ: CPRX) is $25.8291 last updated March 25, 2025 at 11:51 AM EDT.
Does Catalyst Pharmaceuticals (CPRX) pay a dividend?
There are no upcoming dividends for Catalyst Pharmaceuticals.
When is Catalyst Pharmaceuticals (NASDAQ:CPRX) reporting earnings?
Catalyst Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
Is Catalyst Pharmaceuticals (CPRX) going to split?
There is no upcoming split for Catalyst Pharmaceuticals.
What sector and industry does Catalyst Pharmaceuticals (CPRX) operate in?
Catalyst Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.